Please enable JavaScript to continue using this application.

Compare $ILMN vs $WST | Chartloom

Compare

$ILMN vs $WST

Illumina Inc · West Pharmaceutical Services Inc

ILMN

Illumina Inc

WST

West Pharmaceutical Services Inc

Compare $ILMN vs $WST

Comparing Illumina Inc and West Pharmaceutical Services Inc

ILMNIllumina Inc

WSTWest Pharmaceutical Services Inc

ILMNIllumina Inc

Market cap

$42.09B

P/E (TTM)

51.59x

Forward P/E (NTM)

48.10x

Forward P/S (NTM)

8.72x

Rev growth (TTM)

4.9%

YTD performance

107.0%

52W performance

184.5%

FCF yield

2.2%

WSTWest Pharmaceutical Services Inc

Market cap

$25.76B

P/E (TTM)

46.20x

Forward P/E (NTM)

39.00x

Forward P/S (NTM)

7.45x

Rev growth (TTM)

12.4%

YTD performance

32.4%

52W performance

36.6%

FCF yield

1.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ILMN

WST

Detailed metrics comparison

ILMN

Illumina Inc

WST

West Pharmaceutical Services Inc

Market Cap

ILMN$42.09B

WST$25.76B

Enterprise Value

ILMN$43.04B

WST$25.53B

Price

ILMN$278.17

WST$366.00

P/E Ratio

ILMN51.59x

WST46.20x

P/S Ratio

ILMN9.37x

WST7.74x

EV/Sales

ILMN9.58x

WST7.67x

EV/EBITDA

ILMN36.11x

WST28.16x

P/B Ratio

ILMN14.53x

WST8.84x

P/FCF Ratio

ILMN45.21x

WST58.96x

EV/FCF

ILMN46.23x

WST58.44x

PEG Ratio

ILMN4.18x

WST3.05x

Forward P/E (NTM)

ILMN48.10x

WST39.00x

Forward P/S (NTM)

ILMN8.72x

WST7.45x

Revenue (TTM)

ILMN$4.49B

WST$3.33B

Revenue Growth (YoY)

ILMN4.9%

WST12.4%

Forward Rev Growth

ILMN6.3%

WST6.2%

Gross Margin (TTM)

ILMN66.4%

WST36.8%

Operating Margin (TTM)

ILMN19.5%

WST20.4%

EBITDA Margin (TTM)

ILMN26.2%

WST27.0%

Net Margin (TTM)

ILMN18.4%

WST17.0%

FCF Margin (TTM)

ILMN20.7%

WST13.1%

Net Income (TTM)

ILMN$825M

WST$565M

FCF (TTM)

ILMN$931M

WST$437M

EPS (TTM)

ILMN$5.39

WST$7.92

ROE (TTM)

ILMN31.1%

WST18.5%

ROA (TTM)

ILMN12.7%

WST13.6%

ROIC (TTM)

ILMN17.8%

WST17.3%

Cash

ILMN$1.04B

WST$436M

Debt

ILMN$1.99B

WST$207M

Net Cash/Debt

ILMN$-951M

WST$229M

Current Ratio (TTM)

ILMN1.80x

WST2.82x

Quick Ratio (TTM)

ILMN1.25x

WST2.12x

Debt/Equity (TTM)

ILMN0.70x

WST0.07x

Debt/Assets (TTM)

ILMN0.0%

WST0.0%

Interest Coverage (TTM)

ILMNN/A

WSTN/A

Net Debt/EBITDA (TTM)

ILMN0.00x

WST0.00x

Beta

ILMN1.43

WST1.15

52W Performance

ILMN184.5%

WST36.6%

YTD Performance

ILMN107.0%

WST32.4%

% from 52W High

ILMN-10.1%

WST-5.2%

% from 52W Low

ILMN216.1%

WST63.5%

Asset Turnover (TTM)

ILMN0.69x

WST0.80x

FCF Yield (TTM)

ILMN2.2%

WST1.7%

Earnings Yield (TTM)

ILMN2.0%

WST2.2%

Dividend Yield (TTM)

ILMNN/A

WST0.2%

Rule of 40

ILMN25.6

WST25.5

EV/GP/RG

ILMN1.93

WST5.32

Ticker research

View ILMN research View WST research

Metric	ILMN Illumina Inc	WST West Pharmaceutical Services Inc
Market & Valuation
Market Cap	$42.09B	$25.76B
Enterprise Value	$43.04B	$25.53B
Price	$278.17	$366.00
P/E Ratio	51.59x	46.20x
P/S Ratio	9.37x	7.74x
EV/Sales	9.58x	7.67x
EV/EBITDA	36.11x	28.16x
P/B Ratio	14.53x	8.84x
P/FCF Ratio	45.21x	58.96x
EV/FCF	46.23x	58.44x
PEG Ratio	4.18x	3.05x
Forward P/E (NTM)	48.10x	39.00x
Forward P/S (NTM)	8.72x	7.45x
Revenue & Growth
Revenue (TTM)	$4.49B	$3.33B
Revenue Growth (YoY)	4.9%	12.4%
Forward Rev Growth	6.3%	6.2%
Profitability
Gross Margin (TTM)	66.4%	36.8%
Operating Margin (TTM)	19.5%	20.4%
EBITDA Margin (TTM)	26.2%	27.0%
Net Margin (TTM)	18.4%	17.0%
FCF Margin (TTM)	20.7%	13.1%
Net Income (TTM)	$825M	$565M
FCF (TTM)	$931M	$437M
EPS (TTM)	$5.39	$7.92
ROE (TTM)	31.1%	18.5%
ROA (TTM)	12.7%	13.6%
ROIC (TTM)	17.8%	17.3%
Financial Health
Cash	$1.04B	$436M
Debt	$1.99B	$207M
Net Cash/Debt	$-951M	$229M
Current Ratio (TTM)	1.80x	2.82x
Quick Ratio (TTM)	1.25x	2.12x
Debt/Equity (TTM)	0.70x	0.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.43	1.15
52W Performance	184.5%	36.6%
YTD Performance	107.0%	32.4%
% from 52W High	-10.1%	-5.2%
% from 52W Low	216.1%	63.5%
Efficiency & Yields
Asset Turnover (TTM)	0.69x	0.80x
FCF Yield (TTM)	2.2%	1.7%
Earnings Yield (TTM)	2.0%	2.2%
Dividend Yield (TTM)	N/A	0.2%
Other
Rule of 40	25.6	25.5
EV/GP/RG	1.93	5.32
Ticker research	View ILMN research	View WST research

Valuation

P/E Ratio

WST

46.20x

ILMN

51.59x

P/S Ratio

WST

7.74x

ILMN

9.37x

EV/FCF

ILMN

46.23x

WST

58.44x

Growth & revenue

Revenue Growth TTM

WST

12.4%

ILMN

4.9%

Forward Revenue Growth

ILMN

6.3%

WST

6.2%

Profitability & performance

Gross Margin

ILMN

66.4%

WST

36.8%

ROE

ILMN

31.1%

WST

18.5%

FCF Yield %

ILMN

2.2%

WST

1.7%

52-Week Performance

ILMN

184.5%

WST

36.6%

Detailed metrics comparison

ILMN

Illumina Inc

WST

West Pharmaceutical Services Inc

Market Cap

ILMN$42.09B

WST$25.76B

Enterprise Value

ILMN$43.04B

WST$25.53B

Price

ILMN$278.17

WST$366.00

P/E Ratio

ILMN51.59x

WST46.20x

P/S Ratio

ILMN9.37x

WST7.74x

EV/Sales

ILMN9.58x

WST7.67x

EV/EBITDA

ILMN36.11x

WST28.16x

P/B Ratio

ILMN14.53x

WST8.84x

P/FCF Ratio

ILMN45.21x

WST58.96x

EV/FCF

ILMN46.23x

WST58.44x

PEG Ratio

ILMN4.18x

WST3.05x

Forward P/E (NTM)

ILMN48.10x

WST39.00x

Forward P/S (NTM)

ILMN8.72x

WST7.45x

Revenue (TTM)

ILMN$4.49B

WST$3.33B

Revenue Growth (YoY)

ILMN4.9%

WST12.4%

Forward Rev Growth

ILMN6.3%

WST6.2%

Gross Margin (TTM)

ILMN66.4%

WST36.8%

Operating Margin (TTM)

ILMN19.5%

WST20.4%

EBITDA Margin (TTM)

ILMN26.2%

WST27.0%

Net Margin (TTM)

ILMN18.4%

WST17.0%

FCF Margin (TTM)

ILMN20.7%

WST13.1%

Net Income (TTM)

ILMN$825M

WST$565M

FCF (TTM)

ILMN$931M

WST$437M

EPS (TTM)

ILMN$5.39

WST$7.92

ROE (TTM)

ILMN31.1%

WST18.5%

ROA (TTM)

ILMN12.7%

WST13.6%

ROIC (TTM)

ILMN17.8%

WST17.3%

Cash

ILMN$1.04B

WST$436M

Debt

ILMN$1.99B

WST$207M

Net Cash/Debt

ILMN$-951M

WST$229M

Current Ratio (TTM)

ILMN1.80x

WST2.82x

Quick Ratio (TTM)

ILMN1.25x

WST2.12x

Debt/Equity (TTM)

ILMN0.70x

WST0.07x

Debt/Assets (TTM)

ILMN0.0%

WST0.0%

Interest Coverage (TTM)

ILMNN/A

WSTN/A

Net Debt/EBITDA (TTM)

ILMN0.00x

WST0.00x

Beta

ILMN1.43

WST1.15

52W Performance

ILMN184.5%

WST36.6%

YTD Performance

ILMN107.0%

WST32.4%

% from 52W High

ILMN-10.1%

WST-5.2%

% from 52W Low

ILMN216.1%

WST63.5%

Asset Turnover (TTM)

ILMN0.69x

WST0.80x

FCF Yield (TTM)

ILMN2.2%

WST1.7%

Earnings Yield (TTM)

ILMN2.0%

WST2.2%

Dividend Yield (TTM)

ILMNN/A

WST0.2%

Rule of 40

ILMN25.6

WST25.5

EV/GP/RG

ILMN1.93

WST5.32

Ticker research

View ILMN research View WST research

Metric	ILMN Illumina Inc	WST West Pharmaceutical Services Inc
Market & Valuation
Market Cap	$42.09B	$25.76B
Enterprise Value	$43.04B	$25.53B
Price	$278.17	$366.00
P/E Ratio	51.59x	46.20x
P/S Ratio	9.37x	7.74x
EV/Sales	9.58x	7.67x
EV/EBITDA	36.11x	28.16x
P/B Ratio	14.53x	8.84x
P/FCF Ratio	45.21x	58.96x
EV/FCF	46.23x	58.44x
PEG Ratio	4.18x	3.05x
Forward P/E (NTM)	48.10x	39.00x
Forward P/S (NTM)	8.72x	7.45x
Revenue & Growth
Revenue (TTM)	$4.49B	$3.33B
Revenue Growth (YoY)	4.9%	12.4%
Forward Rev Growth	6.3%	6.2%
Profitability
Gross Margin (TTM)	66.4%	36.8%
Operating Margin (TTM)	19.5%	20.4%
EBITDA Margin (TTM)	26.2%	27.0%
Net Margin (TTM)	18.4%	17.0%
FCF Margin (TTM)	20.7%	13.1%
Net Income (TTM)	$825M	$565M
FCF (TTM)	$931M	$437M
EPS (TTM)	$5.39	$7.92
ROE (TTM)	31.1%	18.5%
ROA (TTM)	12.7%	13.6%
ROIC (TTM)	17.8%	17.3%
Financial Health
Cash	$1.04B	$436M
Debt	$1.99B	$207M
Net Cash/Debt	$-951M	$229M
Current Ratio (TTM)	1.80x	2.82x
Quick Ratio (TTM)	1.25x	2.12x
Debt/Equity (TTM)	0.70x	0.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.43	1.15
52W Performance	184.5%	36.6%
YTD Performance	107.0%	32.4%
% from 52W High	-10.1%	-5.2%
% from 52W Low	216.1%	63.5%
Efficiency & Yields
Asset Turnover (TTM)	0.69x	0.80x
FCF Yield (TTM)	2.2%	1.7%
Earnings Yield (TTM)	2.0%	2.2%
Dividend Yield (TTM)	N/A	0.2%
Other
Rule of 40	25.6	25.5
EV/GP/RG	1.93	5.32
Ticker research	View ILMN research	View WST research